Matthew W. Rosinack
Interim Principal Financial Officer and Principal Accounting Officer
Other
Executive changes
-
Appointed interim Principal Financial Officer and Principal Accounting Officer at Iovance Biotherapeutics, Inc. (IOVA)2025-06-30
Earnings-call appearances
No earnings-call appearances recorded yet.